Cancer
Malignant Salivary Gland Neoplasm
CI-CAN-00001175Explore in graph →
Top-level63 active trials13 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001175Explore in graph →
Clinical trials
225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (23)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06091878 | Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers(INDAGA-UK) | unknown | — | 250 | Royal Marsden NHS Foundation TrustOTHER | 0 | Aug 9, 2024 | clinicaltrials |
| NCT03924466 | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients(VUBAR) | unknown | Phase 2 | 55 | Universitair Ziekenhuis BrusselOTHER |
| 1 |
| Feb 16, 2024 |
| clinicaltrials |
| NCT03146650 | Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer | unknown | Phase 2 | 25 | Northwestern UniversityOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT01586767 | Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy | unknown | N/A | 45 | Massachusetts General HospitalOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT05898373 | Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC | unknown | Phase 1 / Phase 2 | 120 | Peking Union Medical CollegeOTHER | 0 | Jun 12, 2023 | clinicaltrials |
| NCT04974866 | Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma | unknown | Phase 2 | 20 | Qingdao Central HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT05727410 | Neoadjuvant Nivolumab, Docetaxel, Cisplatin Therapy Followed by Surgery and Radiation Therapy for Resectable High Grade Salivary Gland Carcinoma | unknown | Phase 2 | 50 | Myung-Ju AhnOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT04214353 | PSMA-PET Imaging Before and After ADT in Advanced SDC Patients(ADT-SCAN) | unknown | N/A | 14 | Radboud University Medical CenterOTHER | 1 | Aug 16, 2022 | clinicaltrials |
| NCT05499936 | 68Ga-FAPI PET/CT for the Detection of Adenoid Cystic Carcinoma(ACC) | unknown | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Aug 12, 2022 | clinicaltrials |
| NCT03614364 | Combination of Nanoxel and Herzuma in Salivary Duct Carcinoma | unknown | Phase 2 | 41 | Samsung Medical CenterOTHER | 1 | Jan 4, 2022 | clinicaltrials |
| NCT03291002 | Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC | unknown | Phase 1 | 98 | CureVacINDUSTRY | 5 | Nov 4, 2021 | clinicaltrials |
| NCT03942380 | Cell-free Tumor DNA in Head and Neck Cancer Patients | unknown | N/A | 500 | Christian von BuchwaldOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT05013515 | Efficacy and Safety of Neoadjuvant Surufatinib for Patients With Salivary Gland Carcinomas | unknown | N/A | 20 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Aug 19, 2021 | clinicaltrials |
| NCT05008237 | Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study | unknown | Phase 2 | 42 | Samsung Medical CenterOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT04801264 | Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617 | unknown | Early Phase 1 | 40 | Peking Union Medical College HospitalOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT02942693 | Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma | unknown | Phase 2 | 50 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Sep 28, 2018 | clinicaltrials |
| NCT02775370 | A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck | unknown | Phase 2 | 68 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Sep 26, 2018 | clinicaltrials |
| NCT02883374 | Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety | unknown | Phase 2 | 30 | Dong meiOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT02964351 | microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer | unknown | — | 120 | Assuta Medical CenterOTHER | 0 | Nov 16, 2016 | clinicaltrials |
| NCT02048254 | Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer | unknown | Phase 3 | 90 | Peking UniversityOTHER | 1 | Jun 13, 2016 | clinicaltrials |
| NCT02401763 | Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis | unknown | — | 200 | National Taiwan University HospitalOTHER | 0 | Apr 3, 2015 | clinicaltrials |
| NCT01192087 | Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy(ACCEPT) | unknown | Phase 1 / Phase 2 | 49 | Heidelberg UniversityOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT00180921 | Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck | unknown | Phase 2 | 30 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 26, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Aug 9, 2024source: clinicaltrials